No Further Workup Needed for Hospice Patients with Gross Hematuria
For patients under hospice care presenting with gross hematuria, further diagnostic workup including imaging or cystoscopy should not be pursued, as the goals of care prioritize comfort and quality of life over cancer detection or curative interventions.
Rationale Based on Goals of Care
The standard guidelines for hematuria evaluation explicitly recommend full urologic workup for all adults with gross hematuria, including cystoscopy and imaging (CT urography), given the 30-40% association with malignancy 1. However, these recommendations are predicated on the assumption that detecting cancer will lead to treatment that improves outcomes.
Why Hospice Status Changes Everything
In hospice care, the fundamental goals shift from:
- Curative intent → Comfort-focused care
- Life prolongation → Quality of remaining life
- Cancer detection → Symptom management
Pursuing diagnostic workup in this population creates harm without benefit:
- CT urography exposes dying patients to radiation, IV contrast (with nephrotoxicity risk), and the discomfort of prolonged positioning
- Cystoscopy is invasive, uncomfortable, carries infection risk, and requires procedural preparation
- Finding cancer would not change management, as hospice patients are not candidates for surgery, chemotherapy, or radiation
- The workup itself contradicts the hospice philosophy of avoiding burdensome interventions
Appropriate Management Instead
Focus exclusively on symptomatic relief:
- If bleeding causes discomfort or clot retention: Consider bladder irrigation, tranexamic acid, or palliative catheterization
- If anemia develops: Treat symptoms (fatigue, dyspnea) rather than the hemoglobin number
- If patient/family distressed by visible blood: Provide reassurance and education about expected disease progression
Common Pitfall to Avoid
Do not reflexively order "routine" hematuria workup simply because guidelines recommend it for the general population. Guidelines assume patients are candidates for treatment 2, 1. When treatment is not aligned with goals of care, diagnostic testing becomes low-value care that increases suffering without improving mortality, morbidity, or quality of life.
The hospice enrollment itself represents a clinical decision that life expectancy is limited (typically <6 months) and that comfort supersedes investigation. This context supersedes all standard hematuria evaluation algorithms.